This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,747.36, is for the delivery of HYPERRAB 300 UNIT/ML VIAL 3ML medical supplies. It is a Firm Fixed Price Delivery Order contract with a completion date of December 9, 2024. The contract was awarded on November 15, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 2/14/25, 9:16 AM